Abstract:The objective of this study was to explore the expression and clinical significance of Notch signaling genes in colorectal cancer. Colorectal cancer samples were prospectively collected from patients post-surgery at the 3rd Affiliated Hospital, Nanjing University of Traditional Chinese Medicine. Immunohistochemistry of tissue arrays was used to analyze the samples and genes involved in the Notch signaling pathway. Microsatellite instability (MSI) was detected by fluorescence multiplex polymerase chain reaction. A total of 146 colorectal cancer samples were collected, including 84 men (57.7%) and 62 women (42.5%). The average age of the study population was 60.8 ± 10.5 years. Notch1 and Notch2 gene expression correlated with tumor pathology type and degree of differentiation. In addition, Jagged 1 (JAG1) and hairy enhancer of split 1 gene expression correlated with the degree of tumor differentiation. Delta-like 1 gene expression varied significantly with tumor location. There was a significant difference between gene expression and MSI. Of the 138 patients, 134 (91.8%) participated in on-site visits, and the average follow-up time was 42.3 ± 13.3 months. During this period, 86 patients (71.6%) were tumor-free. At 1 year post-surgery, 93% of patients were alive, 74% of patients lived for 3 years, and 67% of patients lived for 5 years. The log-rank test was used to perform univariate analysis, and the COX proportional hazards model was used for the multivariate analysis. Based on these analyses, tumor prognosis correlated with the TNM stage, pathological type, microsatellite status as well as Notch2 and JAG1 gene expression. Patients expressing high levels of Notch2 and JAG1 presented with a significantly better prognosis compared to patients expressing negative or weak levels of Notch2 and JAG1. The expression levels of genes associated with the Notch signaling pathway correlated with tumor pathology and the degree of differentiation. In addition, Notch2 and JAG1 expression levels correlated with survival; however, the underlying mechanism for these correlations remains unclear.

Notch1 regulates the expression of its ligand Jagged1 in PC3 prostate cancer cells

Down‐regulation of Notch‐1 and Jagged‐1 Inhibits Prostate Cancer Cell Growth, Migration and Invasion, and Induces Apoptosis Via Inactivation of Akt, Mtor, and NF‐κB Signaling Pathways

Dynamics of Notch Expression During Murine Prostate Development and Tumorigenesis

Notch1 Suppresses Prostate Cancer Cell Invasion Via the Metastasis-Associated 1-Kiss-1 Metastasis-Suppressor Pathway

Notch signaling in prostate cancer: a moving target

Notch Signaling is Required for Normal Prostatic Epithelial Cell Proliferation and Differentiation

The Notch pathway in prostate development and cancer

Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged1 in Prostate Cancer by Enhancing Cyclin B1 Expression Via Akt Phosphorylation

Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model

Notch1-expressing Cells Are Indispensable for Prostatic Branching Morphogenesis During Development and Re-growth Following Castration and Androgen Replacement*

Sirna-Mediated Silencing of Notch-1 Enhances Docetaxel Induced Mitotic Arrest and Apoptosis in Prostate Cancer Cells.

Expression and Clinical Significance of Notch Signaling Genes in Colorectal Cancer

Antitumor Activity of Notch‑1 Inhibition in Human Colorectal Carcinoma Cells.

Activation of Notch Pathway is Linked with Epithelial-Mesenchymal Transition in Prostate Cancer Cells

Silencing Notch-1 Induces Apoptosis and Increases the Chemosensitivity of Prostate Cancer Cells to Docetaxel Through Bcl-2 and Bax

The NOTCH Ligand JAGGED2 Promotes Pancreatic Cancer Metastasis Independent of NOTCH Signaling Activation

NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells

Pharmacological Inhibition of the Notch Pathway Enhances the Efficacy of Androgen Deprivation Therapy for Prostate Cancer.

Notch1 Regulates the Growth of Human Colon Cancers

[Notch Signaling in Human Breast Cancer].

Expression of Jagged 1 Predicts Postoperative Clinical Outcome of Patients with Gastric Cancer